Use LEFT and RIGHT arrow keys to navigate between flashcards;
Use UP and DOWN arrow keys to flip the card;
H to show hint;
A reads text to speech;
14 Cards in this Set
- Front
- Back
Findings from the NHANES study revealed what connection between sxs of metabolic syndrome
|
high BP correlated with high cholesterol and high cholesterol correlated with high BP
|
|
Which body shape is most at risk for development of metabolic syndrome
|
apple shape, central abdominal obesity
|
|
Describe the euglycemic insulin clamp technique
|
used to measure insulin resistance, insulin is infused at a constant rate, glucose is infused at various rates until equilibrium is established. A slower rate indicates insulin resistance
|
|
What did the pioglitazone in DAHL-S salt sensitve hypertensize rats show?
|
Using drugs to increase insulin sensitivity decreased blood pressure, demonstrated linked between insulin resistance and high bp
|
|
Describe the phenotype of insulin receptor knockout mice. What evidence did this provide concerning the cause of metabolic syndrom
|
Mice lacking the insulin receptor had hypertension, high TG, low HDL, and impaired endothelium dependent vasodilation
|
|
Describe the association of insulin resistance with the determinates of arterial pressure
|
-increased HR
-decreased SV -decreased CO -increased PR overall effect is increased arterial pressure |
|
The prothromobotic manifestations of metabolic syndrome include
|
-decreased plasminogen activator and increased activator inhibitor
-increased fibrinogen -increased blood viscosity |
|
In addition to the "deadly quartet" of sxs such as hypertension and dislipidemia, metabolic syndrome is associated with which disorders affecting "peripheral systems"
|
-NASH
-PCOS -obstructive sleep apnea -asthma -gallstones |
|
Describe the changes in adiopokines/ inflammatory markers that are associated with metabolic syndrome
|
increase in: leptin, resistin, interluekins, TNF, C reative protein
decrease in-adiponectin (anti-atherogenic) |
|
What are the criteria for Dx'ing metabolic syndrome
|
3 or more of:
central obesity triglycerides >150 HDL <40 men, <50 women hypertension >130/85 fasting glucose >110 |
|
How does the prevalence of metabolic syndrome vary with age
|
20-29 7%
60-69 44% >70 42% |
|
The most important aspect of treatment for metabolic syndrome is
|
weight reduction (caloric restriction, therapy, activity, drugs, surgery)
**just at 10% reduction is beneficial!! |
|
What are the dietary goals of Tx for meatbolic syndrome
|
-<7% of calories from saturted fat
-cholesterol <200mg/day -limit trans fats <6gm saltday -restrict alcohol |
|
What drugs can be used to Tx metabolic syndrome
|
-weight loss drugs (appetite/absportion)
-statins -bile acid sequestrants -fenogibrate to increase HDL (?) -antihypertensives |